Colistimethate for Injection, USP, 150mg is generic equivalent of JHP Pharmaceuticals’s Coly-Mycin M parenteral. APP has immediately commenced marketing and shipping the product. APP’s colistimethate is AP-rated, bar-coded and latex-free.
Colistimethate is indicated for the treatment of acute or chronic infections due to sensitive strains of certain gram-negative bacilli. It is particularly indicated when the infection is caused by pseudomonas aeruginosa.